Multicentre analysis of patterns of DNA gains and losses in 204 neuroblastoma tumors: How many genetic subgroups are there?

Medical and Pediatric Oncology

Volumn 36, Issue 1, 2001, Pages 5-10

  Vandesompele, Jo ^a   Speleman, Frank ^a   Van Roy, Nadine ^a   Laureys, Genevi Ve ^a   Brinkschmidt, Christian ^d   Christiansen, Holger ^e   Lampert, Fritz ^f   Lastowska, Maria ^g   Bown, Nick ^g   Pearson, Andy ^g   Nicholson, James C ^h   Ross, Fiona ^h   Combaret, Val Rie ⁱ   Delattre, Olivier ^j   Feuerstein, Bert G ^c   Plantaz, Dominique ^b  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b GRENOBLE UNIVERSITY HOSPITAL   (France)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^e PHILIPPS UNIVERSITY MARBURG   (Germany)

^f Univ Kinderklinik of Gie en   (Germany)

^g NEWCASTLE UNIVERSITY   (United Kingdom)

^h SALISBURY DISTRICT HOSPITAL   (United Kingdom)

ⁱ Lé on Bé rard Center   (France)

^j INSTITUT CURIE   (France)

more..

Author keywords

CGH; Genetic subgroup; Neuroblastoma

Indexed keywords

DNA;

CANCER STAGING; CHROMOSOME 11Q; CHROMOSOME 14Q; CHROMOSOME 17Q; CHROMOSOME 1P; CHROMOSOME 3P; CHROMOSOME 4P; CHROMOSOME ABERRATION; COMPARATIVE GENOMIC HYBRIDIZATION; CONFERENCE PAPER; CYTOGENETICS; GENE AMPLIFICATION; GENETIC ANALYSIS; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; NEUROBLASTOMA; ONCOGENE; ONCOGENE MYCN; PRIORITY JOURNAL; PROGNOSIS;

CHROMOSOME ABERRATIONS; CHROMOSOME DELETION; CHROMOSOMES, HUMAN; DNA, NEOPLASM; HUMANS; LOSS OF HETEROZYGOSITY; NEOPLASM STAGING; NEUROBLASTOMA; NUCLEIC ACID HYBRIDIZATION; PROGNOSIS; TRISOMY;

EID: 0035171136     PISSN: 00981532     EISSN: None     Source Type: Journal    
DOI: 10.1002/1096-911X(20010101)36:1<5::AID-MPO1003>3.0.CO;2-E     Document Type: Article

References (33)

1. Molecular biology and genetics of human neuroblastoma
2. Clinical relevance of tumor cell ploidy and N-myc gene amplification in childhood neuroblastoma: A Pediatric Oncology Group study
3. 1p36: Every subband a suppressor?
4. Genomic instability in 1p and human malignancies
5. Frequent loss of heterozygosity on chromosome 14q in neuroblastoma
6. Loss of heterozygosity for chromosomes 1 or 14 defines subsets of advanced neuroblastomas
7. Deletion mapping of chromosomes 14q and 1p in human neuroblastoma
8. Deletion of chromosome 11 and of 14q sequences in neuroblastoma
9. Allelic loss of the short arm of chromosome 4 in neuroblastoma suggests a novel tumor suppressor gene locus
10. Allelotype of neuroblastoma
11. Deletion map of chromosome 9 and p16 (CDKN2A) gene alterations in neuroblastoma
12. Representational difference analysis and loss of heterozygosity studies detect 3p deletions in neuroblastoma
13. Human neuroblastomas and abnormalities of chromosomes 1 and 17
14. Translocation involving 1p and 17q is a recurrent genetic alteration of human neuroblastoma cells
15. 1;17 Translocations and other chromosome 17 rearrangements in human primary neuroblastoma tumors and cell lines
16. Molecular cytogenetic analysis of 1;17 translocations in neuroblastoma
17. Recurrent 1;17 translocations in human neuroblastoma reveal nonhomologous mitotic recombination during the S/G2 phase as a novel mechanism for loss of heterozygosity
18. Additional copies of a 25 Mb chromosomal region originating from 17q23.1-17qter are present in 90% of high-grade neuroblastomas
19. Promiscuous translocations of chromosome arm 17q in human neuroblastomas
20. Analysis of 1;17 translocation breakpoints in neuroblastoma: Implications for mapping of neuroblastoma genes
21. Minimal sizes of deletions detected by comparative genomic hybridization
22. Novel regions of chromosomal loss in familial neuroblastoma by comparative genomic hybridization
23. Comparative genomic hybridization (CGH) analysis of neuroblastomas - An important methodological approach in paediatric tumor pathology
24. Comparative genomic hybridization study of primary neuroblastoma tumors
25. Sensitive and reliable detection of genomic imbalances in human neuroblastomas using comparative genomic hybridization analysis
26. Comparative genomic hybridization analysis of human neuroblastomas: Detection of distal 1p deletions and further molecular genetic characterization of neuroblastoma cell lines
27. Gain of chromosome 17 is the most frequent abnormality detected in neuroblastoma by comparative genomic hybridization
28. Genetic heterogeneity of neuroblastoma studied by comparative genomic hybridization
29. Detection of complete and partial chromosome gains and losses by comparative genomic in situ hybridization
30. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors
31. Current status of cytogenetic research in childhood acute lymphoblastic leukemia
32. An increased NM23H1 copy number may be a poor prognostic factor independent of LOH on 1p in neuroblastomas
33. The involvement of the chromosome 11q13 region in human malignancies: Cyclin D1 and EMS1 are two new candidate oncogenes - A review